...
首页> 外文期刊>Rheumatology international. >Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.
【24h】

Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.

机译:口服甲氨蝶呤治疗特发性肥厚性颅脑膜炎:一例病例并文献复习。

获取原文
获取原文并翻译 | 示例
           

摘要

Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare clinical entity, characterized by a chronic inflammation causing thickening of the dura. Adequate therapeutic management is still a matter of debate. We present a patient with an IHCP, non-responsive to corticotherapy. Oral methotrexate was introduced (12.5 mg weekly) and total remission was observed after 6 weeks, both clinically and after neuro-imaging. We conclude that methotrexate can be effective and a therapeutical option in patients with IHCP who are resistant to corticotherapy or present major side-effects of chronic corticosteroids use.
机译:特发性肥厚性颅脑膜脑膜炎(IHCP)是一种罕见的临床实体,其特征是慢性炎症引起硬脑膜增厚。充分的治疗管理仍是一个争论的问题。我们向患者介绍对皮质疗法无反应的IHCP。口服甲氨蝶呤(每周12.5 mg),并在6周后临床和神经影像学观察到总缓解。我们得出的结论是,甲氨蝶呤对于抵抗皮质激素治疗或目前长期使用皮质类固醇的主要副作用的IHCP患者可能是有效的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号